Cargando…
Chinese medicine Gushukang capsule for treating primary osteoporosis: a systematic review and meta-analysis
OBJECTIVE: To systematically evaluate the efficacy and safety of Gushukang (GSK) capsules in the treatment of primary osteoporosis. METHODS: Randomized controlled trials related to the treatment of primary osteoporosis were collected through online retrieval of the China National Knowledge Infrastru...
Autores principales: | Liu, Tianpeng, Yao, Menglin, Zhao, Yifan, Zhao, Shaochuan, Rui, Chen, Yang, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631217/ https://www.ncbi.nlm.nih.gov/pubmed/37940992 http://dx.doi.org/10.1186/s13018-023-04264-9 |
Ejemplares similares
-
Integrated proteomics and metabolomics analysis of lumbar in a rat model of osteoporosis treated with Gushukang capsules
por: Lin, Ruohui, et al.
Publicado: (2022) -
Effects of Gushukang for postmenopausal osteoporosis: A protocol for systematic review and meta-analysis
por: Wang, Guangwei, et al.
Publicado: (2020) -
Positive Effect of Gushukang on Type-H Vessel and Bone Formation
por: Li, Wantao, et al.
Publicado: (2020) -
Qianggu capsule for the treatment of primary osteoporosis: evidence from a Chinese patent medicine
por: Wei, Xu, et al.
Publicado: (2017) -
Chinese Proprietary Medicine Xianling Gubao Capsule for Osteoporosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Cheng, Bai-Ru, et al.
Publicado: (2022)